跳至主要内容
临床试验/JPRN-UMIN000008151
JPRN-UMIN000008151已完成未知

Controlled Anti-platelet medical therapy based on rapid CYP2C19 gene evaluation in Acute myocardial infarction - CALDERA-GENE STUDY

Graduate School of Medical Sciences, Kumamoto University0 个研究点目标入组 100 人开始时间: 2012年6月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • We exclude patients with deep vein thrombosis, cerebral infarction, atrial fibrillation, collagen disease ,disseminated intravascular coagulation, sepsis, severe infection and malignant diseases. We exclude patients who were treated with warfarin, steroids, thrombolytic agents, ticlopidine, sarpogrelate or cilostazol. We exclude patients with severe liver or renal dysfunction. We exclude patients who need mechanical cardio-plumonary supports such as intraaortic balloon pumping(IABP) or percutaneous cardiopulmonary support(PCPS).

研究者

发起方
Graduate School of Medical Sciences, Kumamoto University

相似试验

Controlled Anti-platelet medical therapy based on... | 临床试验